FDA Warning Letter Close-Outs – May 2021
Resolved quality systems problems and MDR violations lay behind the four device-related close-out letters posted online by the US FDA in May.
You may also be interested in...
The US FDA panel will look at a PMA for the TransMedics OCS Liver System, which helps keep donor livers stable and healthy as they await transplant.
The report outlines the lawsuits that the Food and Drug Law Institute believes could have the greatest impacts on industries regulated by the US FDA.
The 17 September session will home in on the details of spinal device regulation, including adverse event reporting and efforts to increase diversity in study populations.